P4‐356: Safety and Efficacy 31 Week Data of Anavex 2‐73 in a Phase 2A Study in Mild‐Moderate Alzheimer'S Disease Patients. (1st July 2016) - Macfarlane, Stephen; Cecchi, Marco; Moore, Dennis; Maruff, Paul; Zografidis, Tasos; Missling, Christopher